Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1
- 25 October 2001
- journal article
- Published by Springer Nature in Oncogene
- Vol. 20 (48) , 6983-6993
- https://doi.org/10.1038/sj.onc.1204892
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 68 references indexed in Scilit:
- Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during LymphomagenesisMolecular and Cellular Biology, 2001
- E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivationOncogene, 2001
- The Max Network Gone MadMolecular and Cellular Biology, 2001
- Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathwaysOncogene, 1997
- bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice.The Journal of Experimental Medicine, 1996
- c-Myc and apoptosisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1995
- Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.Genes & Development, 1994
- Direct role for Myc in transcription initiation mediated by interactions with TFII-INature, 1993
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- myc oncogenes: activation and amplificationBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1987